Standard Biotools Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +46.5% | -8.0% | -1.4% | -22.5% | -29.4% | +39.5% | +72.1% | +59.2% | +296.8% | +11.3% | +3.7% | -10.9% | +7.1% | -10.2% | +1.7% | -7.2% | +1.0% | +11.1% | -89.8% | |
| – | +388.3% | +185.6% | +4.4% | -24.9% | +76.5% | +46.1% | +57.5% | +225.3% | -19.6% | -17.7% | -34.4% | +21.2% | +3.4% | +26.8% | +11.4% | -7.6% | -11.8% | +141.8% | -6.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +104.7% | -34.3% | +10.3% | +66.5% | – | – | – | |
| – | – | -580.4% | – | – | -153.0% | – | – | -216.7% | – | – | +93.7% | -126.9% | – | – | -845.9% | – | – | -775.9% | – | |
| – | -66.8% | -6.5% | -12.2% | +92.6% | +8.9% | +42.2% | +96.6% | +58.0% | +43.9% | -52.5% | -68.1% | -77.0% | +580.4% | +402.4% | +4.3% | -71.2% | -26.0% | +195.1% | -0.6% | |
| – | +129.0% | – | -111.5% | +93.8% | +3,284.1% | – | -296.9% | +547.1% | – | +75.2% | -60.8% | -73.3% | -932.8% | – | -129.9% | +637.7% | – | +1,694.6% | -93.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -26.5% | – | +109.1% | -101.0% | -27.0% | +290.6% | -56.8% | +599.5% | +656.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +414.7% | +0.0% | -65.6% | -137.1% | +2,933.7% | -100.0% | |
| – | +20.7% | -83.2% | +167.8% | -77.6% | +1,753.2% | -31.0% | -88.0% | +3,350.3% | -97.4% | -98.6% | +38,053.9% | +98.8% | -95.2% | +647.6% | -23.5% | +1,345.9% | -103.0% | +1,407.1% | – | |
| – | +54.7% | -279.7% | – | – | – | +475.9% | -151.9% | – | – | – | +288.2% | +62.3% | -291.9% | – | -187.5% | – | -156.4% | – | -141.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.